Oramed Pharmaceuticals
ORMP
#9092
Rank
S$0.15 B
Marketcap
S$3.92
Share price
4.66%
Change (1 day)
18.67%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): -S$6.63 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are S$2 Million. In 2024 the company made an earning of S$0.45 Million a decrease over its 2023 earnings that were of S$9.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$6.63 Million-1552.32%
2024 S$0.45 M-95.05%
2023 S$9.2 M-119.45%
2022 -S$47.32 Million39.17%
2021 -S$34 Million73.93%
2020 -S$19.55 Million18.53%
2019 -S$16.49 Million-16.62%
2018 -S$19.78 Million38.32%
2017 -S$14.3 Million12.51%
2016 -S$12.71 Million25.01%
2015 -S$10.17 Million18.18%
2014 -S$8.61 Million39.72%
2013 -S$6.16 Million46.4%
2012 -S$4.21 Million128.32%
2011 -S$1.85 Million-51.47%
2010 -S$3.8 Million35.21%
2009 -S$2.81 Million
2007 -S$4.42 Million607.04%
2006 -S$0.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-S$0.67 Billion 12,138.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$26.92 B-491,978.24%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$11.75 B-214,830.06%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-S$35.61 Million 550.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-S$88.59 Million 1,518.17%๐Ÿ‡บ๐Ÿ‡ธ USA